Favorable Real-World Outcomes of Lisocabtagene Maraleucel in Chronic Lymphocytic Leukemia

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Jennifer Jing Huang, Jenna M. Voutsinas, Niranjan Shiwaji Khaire, Vincenzo J. Pizzuti, Leyla Osman Shune, Matthew M. Lei, Rodrigo Fonseca, Mohammad Ammad-Ud-Din, Alan Pierre Zausner Skarbnik, Agrima Mian, Sushma Bharadwaj, Aseel Alsouqi
+26 more Bret Wankel, Graham T. Wehmeyer, Joseph Lukowski, Alexey V. Danilov, Tanya Siddiqi, Meghan Thompson, Michael Scordo, Stephanie Franco, Chaitra Shankar Ujjani, Ryan C. Lynch, Jordan Gauthier, William G. Wierda, Paul M. Barr, Adam S. Kittai, Jonah Shulman, Matthew Alexander Lunning, Kerry A. Rogers, Bita Fakhri, Brian Thomas Hill, Javier A. Pinilla-Ibarz, Talal Hilal, Jacob Drobnyk Soumerai, Manali Kirtikumar Kamdar, Qian Vicky Wu, Nitin Jain, Mazyar S. Shadman
DOI: 10.1016/j.jtct.2025.12.080
Cited by: 0

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research CAR-T cell therapy research Acute Lymphoblastic Leukemia research

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S51–S52
Publication date
1 February 2026
Language
EN